RNA Based Therapeutics and Vaccines Market to value over USD 800 Million by 2029 end and register a CAGR of over 58.4% from 2020 to 2029.

The primary aim of RNA therapeutics is to discover a cure for unmet clinical conditions and rare diseases. Since this field is research-based, the advancements in technology aides expand the market and its geographical expanse. Development of promising technologies such as antisense technology, SMaRT technology, and RNAi interference technology provides optimistic future opportunities for the market’s and looks promising. 

The RNA based therapeutics and vaccine market primarily find cures for cancer and infectious diseases and since the pool of patients is large, the demand for the market subsequently is also high. This creates a huge opportunity globally for RNA based Therapeutics and Vaccines market. The lack of alternative treatment options for rare diseases further boosted the growth of RNA-based therapeutics and vaccines during the forecast period. Aiding the growth of this market, increasing focus of legislative bodies on developing reimbursement policies has fueled the development process RNA’s molecules.

Non-profit organizations have invested their financial capabilities to advance the development of RNA therapeutics due to the increasing demand for these therapeutics due to their application for unmet medical conditions. Expensive research and high failure rates are anticipated to restrain the RNA based therapeutics and vaccines market.

RNA based therapeutics and vaccines market accounts major share in North America due to the increasing importance of RNA drugs in treating rare medical diseases. The U.S. is expected to remain dominant over other countries during the forecast period. RNA based Therapeutics and Vaccines market find substantial application in Europe due to increasing RNA research activities in association with government organizations. The high prevalence of infectious diseases in the Asia Pacific is expected to offer huge opportunities for RNA based Therapeutics and Vaccines market.

Major firms in the market are:

Alnylam Pharmaceuticals, Inc., Arbutus Biopharma Corp., Arrowhead Pharmaceuticals, Inc., BioNTech AG, CureVac AG, Dicerna Pharmaceuticals, Inc., Regulus Therapeutics, Inc. and Marina Biotech, Inc. Manufacturers focus on collaborations and partnerships in order to keep the pace of research activities when compared with competitors. 

For instance, in 2018, Regeneron Pharmaceuticals, Inc. and Alnylam Pharmaceuticals, Inc. entered into a collaboration to develop RNAi therapeutics for the chronic liver disease non-alcoholic steatohepatitis (NASH) and potentially other related diseases. In 2017, Arbutus Biopharma Corporation and Gritstone Oncology entered into collaboration and license agreement. Arbutus is deploying its proprietary lipid nanoparticle (LNP) technology to deliver Gritstone’s RNA-based neoantigen immunotherapy products.
Firms such as Alnylam Pharmaceuticals and Arrowhead Pharmaceuticals, Inc., recently received the FDA orphan drug designation – which is foreseen to the market growth outlook over the next few years.

RNA based Therapeutics and Vaccines Market

RNA based Therapeutics and Vaccines Market Segmentation:
By Product Type
• RNA-based Therapeutics
  o siRNA
  o miRNA
• RNA-based Vaccines
  o mRNA

By Indication Type
• Oncology
• Immunology
• Ophthalmology
• Cardiovascular Diseases
• Infectious Diseases
• Genetic Diseases
• Others

By Region
• Europe  
• North America  
• APAC  
• Latin America
• Rest of World 

Competitive Landscape:  
●    Tier 1 players- established companies in the market with a major market share  
●    Tier 2 players 
●    Emerging players which are growing rapidly 
●    New Entrants  

FutureWise Key Takeaways  
●    Growth prospects 
●    SWOT analysis 
●    Key trends 
●    Key data points affecting market growth  

Objectives of the Study: 
●    To provide an exhaustive analysis on RNA based therapeutics and vaccines market based on product type, indication and region
●    To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) 
●    To evaluate and forecast micro-markets and overall market  
●    To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa 
●    To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions 
●    Profiling of companies to evaluate their market shares, strategies, financials and core competencies 

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com


Need Assistance


UK : +44 141 628 9353
US : +1 347 709 4931


Contact Sales

What you get

  • Excel Dataset

  • Infographics

  • PDF Report

  • Market Overview

  • PowerPoint Presentation

What's included

  • Consumer Perception and Procurement

  • Competitive Analysis

  • What’s Next

  • Market Data Forecast

  • Risks and Opportunity Assessment

  • Market Trends and Dynamics